Shrestha Abhigan Babu, Aryal Manjil, Magar Junu Rana, Shrestha Sajina, Hossainy Labiba, Rimti Fahmida Hoque
M Abdur Rahim Medical College, Rajshahi University, Dinajpur, Bangladesh.
Central Institute of Science and Technology, Pokhara University, Kathmandu, Nepal.
Ann Med Surg (Lond). 2022 Oct;82:104482. doi: 10.1016/j.amsu.2022.104482. Epub 2022 Aug 27.
Self-medication association with an ongoing pandemic is evident in the studies conducted throughout the world. To summarize the findings of previous papers, we carried out a systematic review to observe the current scenario of self-medication during COVID-19.
Scopus, Embase, Web of Science, PubMed, MedRxiv preprints, SciELO Preprints, google, and google scholar were searched using keywords related to the topic. Studies reporting original data and assessing the self-medication practices during Covid-19 were included.
A total of 660 papers were collected and 14 cross-sectional studies among them were finalized from 12 different countries after apposite screening processes. Our study measured that during the COVID-19 pandemic, there was a 44.786% prevalence of self-medication. Analgesics, antibiotics, and nutritional supplements were commonly practiced drugs. Pharmacy and hospital outlets were the main sources of the drugs. Fever, sore throat, body ache (muscle pain), and flu or cough were among the most frequently recorded illnesses; treatment and prevention of COVID-19 were the main culprit behind self-medication. During COVID-19, the major factors associated with self-medication were fear, anxiety, and perception regarding COVID-19. Thus, in this pandemic, fear, anxiety, and rumors regarding immunity boosters, nutritional supplements, financial burden, and easy accessibility to even non-OTC drugs; all have their fair share in self-medication practices.
As there was heterogeneity regarding COVID-19 and self-medication found among the assessed studies, educating general people about safe self-medication practices, hazards of superfluous drug usage, and provision of an affordable quality-health system should become a priority, especially in low and middle-income countries.
在全球开展的研究中,自我药疗与当前大流行之间的关联显而易见。为总结先前论文的研究结果,我们进行了一项系统综述,以观察新冠疫情期间自我药疗的现状。
使用与该主题相关的关键词,检索了Scopus、Embase、科学网、PubMed、MedRxiv预印本、SciELO预印本、谷歌及谷歌学术。纳入报告原始数据并评估新冠疫情期间自我药疗行为的研究。
共收集到660篇论文,经过适当筛选流程后,最终从12个不同国家确定了14项横断面研究。我们的研究测算出,在新冠疫情期间,自我药疗的患病率为44.786%。镇痛药、抗生素和营养补充剂是常用药物。药店和医院药房是药物的主要来源。发热、喉咙痛、身体疼痛(肌肉疼痛)以及流感或咳嗽是最常记录的病症;对新冠的治疗和预防是自我药疗的主要原因。在新冠疫情期间,与自我药疗相关的主要因素是恐惧、焦虑以及对新冠的认知。因此,在这场大流行中,对免疫增强剂、营养补充剂的恐惧、焦虑和谣言,经济负担以及甚至非非处方药的容易获取;所有这些在自我药疗行为中都起到了一定作用。
由于在所评估的研究中发现新冠疫情与自我药疗存在异质性,对普通民众进行安全自我药疗行为教育、过度用药的危害教育以及提供负担得起的高质量医疗体系应成为优先事项,尤其是在低收入和中等收入国家。